Last reviewed · How we verify
NCT07319325
Efficacy of Adaptive, Gamified Digital Therapeutics Intervention for Individuals With Methamphetamine Use Disorder in Community Rehabilitation
NA trial testing WonderLab Harbor+ (Adaptive DTx) in Methamphetamine Addiction in 360 participants. Completed in 30 November 2025.
1 October 2025
Quick facts
| Lead sponsor | Adai Technology (Beijing) Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 360 |
| Start date | 1 January 2025 |
| Primary completion | 1 October 2025 |
| Estimated completion | 30 November 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- WonderLab Harbor+ (Adaptive DTx)
- Standard Community Counseling
Conditions studied
- Methamphetamine Addiction — all drugs for Methamphetamine Addiction →
Sponsor
Adai Technology (Beijing) Co., Ltd.
Who can join
Adults 18 to 60, any sex, with Methamphetamine Addiction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the efficacy of a comprehensive, adaptive digital therapeutics (DTx) smartphone application compared to treatment as usual (TAu) for individuals with Methamphetamine Use Disorder (MUD) receiving community-based rehabilitation. The intervention integrates Internet-based Cognitive Behavioral Therapy (ICBT), adaptive Approach Bias Modification (A-ApBM), cognitive training, and contingency management. The primary hypothesis is that the DTx intervention will result in a greater reduction in cue-induced craving compared to standard community care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07319325
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Adai Technology (Beijing) Co., Ltd. trials
Trials by the same sponsor.
- NCT06778785 — Game-Based Digital Intervention for Depression in Adolescents · NA · active not recruiting
- NCT06349993 — Digital Intervention for Depression and Anxiety in Adolescents · NA · recruiting
- NCT06423443 — Digital Cognitive Behavioral Therapy for Depressive Disorders · NA · recruiting
- NCT06301555 — Game-Based Digital Intervention for Relieving Depression and Anxiety Symptoms · NA · completed
- NCT05554289 — Efficacy, Safety, and Acceptability of Internet-based Cognitive Behavioral Therapy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07319325 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Adai Technology (Beijing) Co., Ltd.
- Last refreshed: 6 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07319325.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing